Cefpimizole
Chemical compound
- none
- In general: ℞ (Prescription only)
- 2-[1-([(6R,7R)-2-carboxy-7-([(2R)-2-[(5-carboxy1H-imidazole-4-carbonyl)amino]-2-phenylacetyl]amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl)pyridin-1-ium-4-yl]ethanesulfonate
- 84880-03-5 Y
- 11765031
- 61863 N
- 24S58UHU7N
- D03427 Y
- ChEMBL2103902 N
- DTXSID70920069
- Interactive image
- C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)C4=C(N=CN4)C(=O)O)C(=O)[O-])C[N+]5=CC=C(C=C5)CCS(=O)(=O)O
InChI
- InChI=1S/C28H26N6O10S2/c35-23(18(16-4-2-1-3-5-16)31-24(36)19-20(27(38)39)30-14-29-19)32-21-25(37)34-22(28(40)41)17(13-45-26(21)34)12-33-9-6-15(7-10-33)8-11-46(42,43)44/h1-7,9-10,14,18,21,26H,8,11-13H2,(H5-,29,30,31,32,35,36,38,39,40,41,42,43,44)/t18-,21-,26-/m1/s1 N
- Key:LNZMRLHZGOBKAN-KAWPREARSA-N N
Cefpimizole (INN) is a third-generation cephalosporin antibiotic.
References
- Hara K, Shimada J (June 1987). "[New antimicrobial agent series XXI: Cefpimizole]". The Japanese Journal of Antibiotics (in Japanese). 40 (6): 1108–22. PMID 3312705.
External links
- Media related to Cefpimizole at Wikimedia Commons
- v
- t
- e
(inhibit synthesis
of peptidoglycan
layer of bacterial
cell wall by binding
to and inhibiting
PBPs, a group of
D-alanyl-D-alanine
transpeptidases)
Glycopeptides Lipoglycopeptides |
|
---|---|
Lipopeptides |
|
Polymyxins |
|
Other |
|
- Inhibit PG subunit synthesis and transport: NAM synthesis inhibition (Fosfomycin)
- DADAL/AR inhibitors (Cycloserine)
- bactoprenol inhibitors (Bacitracin)
- Hydrolyze NAM-NAG
- Tyrothricin
- Isoniazid#
- Teixobactin
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This stereochemistry article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e